GlassScriptPhysician profile
Bonnie Wallace
NPI 1770844300
$1,016.15
in general payments reported to CMS, 2019-2025
16 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $238 · 2023: $323 · 2024: $338 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $777.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $181.15 | 2021-2024 | Repatha |
| Abiomed | $172.33 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $130.25 | 2024 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $116.55 | 2025 | |
| Novartis Pharmaceuticals Corporation | $98.87 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.94 | 2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $43.59 | 2023 | Xarelto |
| Novo Nordisk INC | $40.44 | 2024 | Rybelsus, Ozempic |
| Impulse Dynamics (USA) INC. | $34.71 | 2023 | Optimizer |
| Kiniksa Pharmaceuticals, LTD. | $31.06 | 2023 | Arcalyst |
| Ethicon US, LLC | $28.28 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $21.05 | 2024 | Evkeeza |
| E.R. Squibb & Sons, L.L.C. | $19.93 | 2024 | Eliquis |
| Esperion Therapeutics, INC. | $16.96 | 2023 | Nexletol |
| Kiniksa Pharmaceuticals International, Plc | $16.25 | 2024 | Arcalyst |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15.79 | 2024 | Amplatzer Talisman |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bonnie Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.